Myocardial injection of CA promoter-based plasmid mediates efficient transgene expression in rat heart

Journal of Gene Medicine

Volumn 5, Issue 10, 2003, Pages 900-908

  Huang, Jianhua ^a   Ito, Yoshinori ^a   Kobune, Masayoshi ^a   Sasaki, Katsunori ^a   Nakamura, Kiminori ^a   Dehari, Hironari ^a   Takahashi, Kazuhiro ^a   Ikeda, Katsuya ^a   Uchida, Hiroaki ^a   Kato, Kazunori ^a   Hamada, Hirofumi ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenovirus vector; CA promoter; CMV promoter; Gene therapy; Heart; Naked plasmid injection

Indexed keywords

ADENOVIRUS VECTOR; BETA ACTIN; BETA GALACTOSIDASE; LUCIFERASE; VASCULOTROPIN; VIRUS VECTOR; ACTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME ACTIVITY; ENZYME ASSAY; GENE DELETION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; SIMIAN VIRUS; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS REPLICATION; ANIMAL; COMPARATIVE STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HEART MUSCLE; INJECTION; LACTOSE OPERON; LEWIS RAT; METABOLISM; PROMOTER REGION;

ACTINS; ANIMALS; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS; LAC OPERON; MALE; MUSCLE, SKELETAL; MYOCARDIUM; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RATS, INBRED LEW; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0142091736     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.429     Document Type: Article

References (56)

1. Pepper MS. Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 1997; 17: 605-619.
2. Isner JM. Myocardial gene therapy. Nature 2002; 415 234-239.
3. Barr E, Carroll J, Kalynych AM, et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994; 1: 51-58.
4. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994; 90: 2414-2424.
5. Gilgenkrantz H, Duboc D, Juillard V, et al. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum Gene Ther 1995; 6: 1265-1274.
6. Nuss HB, Johns DC, Kaab S, et al. Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: a prototype for gene therapy for disorders of cardiac excitability and contractility. Gene Ther 1996; 3: 900-912.
7. Quinones MJ, Leor J, Kloner RA, et al. Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation 1996; 94: 1394-1401.
8. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
9. Acsadi G, Jiao SS, Jani A, et al. Direct gene transfer and expression into rat heart in vivo. New Biol 1991; 3: 71-81.
10. Dowty ME, Williams P, Zhang G, Hagstrom JE, Wolff JA. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc Natl Acad Sci U S A 1995; 92: 4572-4576.
11. Lee Y, Park EJ, Yu SS, Kim DK, Kim S. Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases. Biochem Biophys Res Commun 2000; 272: 230-235.
12. Wright MJ, Wightman LM, Latchman DS, Marber MS. In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther 2001; 8: 1833-1839.
13. Wright MJ, Wightman LM, Lilley C, et al. In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol 2001; 96: 227-236.
14. Lin H, Parmacek MS, Morle G, Bolling S, Leiden JM. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990; 82: 2217-2221.
15. Kass-Eisler A, Falck-Pedersen E, Alvira M, et al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A 1993; 90: 11 498-11 502.
16. Foecking MK, Hofstetter H. Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene 1986; 45: 101-105.
17. Isner JM, Walsh K, Symes J, et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther 1996; 7: 959-988.
18. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-1123.
19. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-2804.
20. Vale PR, Isner JM, Rosenfield K. Therapeutic angiogenesis in critical limb and myocardial ischemia. J Interv Cardiol 2001; 14 511-528.
21. Losordo DW, Vale PR, Hendel RC, et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012-2018.
22. Zhang G, Budker V, Williams P, Subbotin V, Wolff JA. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther 2001; 12: 427-438.
23. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193-199.
24. Doll RF, Crandall JE, Dyer CA, Aucoin JM, Smith FI. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors. Gene Ther 1996; 3: 437-447.
25. Oberg KC, Pira CU, Revelli JP, Ratz B, Aguilar-Cordova E, Eichele G. Efficient ectopic gene expression targeting chick mesoderm. Dev Dyn 2002; 224: 291-302.
26. Chung S, Andersson T, Sonntag KC, Bjorklund L, Isacson O, Kim KS. Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells 2002; 20: 139-145.
27. Akagi Y, Isaka Y, Akagi A, et al. Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and beta-actin/beta-globin gene in glomerular epithelial cells in vivo. Kidney Int 1997; 51: 1265-1269.
28. Honda H, Harada K, Komuro I, et al. Heart-specific activation of LTK results in cardiac hypertrophy, cardiomyocyte degeneration and gene reprogramming in transgenic mice. Oncogene 1999; 18: 3821-3830.
29. Ray PS, Martin JL, Swanson EA, Otani H, Dillmann WH, Das DK. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. Faseb J 2001; 15: 393-402.
30. Tani K, Lin T, Hibino H, et al. Transduction of LacZ gene into leukemia cells using viral vectors of retrovirus and adenovirus. Leukemia 1995; 9(Suppl 1): S64-65.
31. Kiwaki K, Kanegae Y, Saito I, et al. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter. Hum Gene Ther 1996; 7: 821-830.
32. Tsujino S, Kinoshita N, Tashiro T, et al. Adenovirus-mediated transfer of human acid maltase gene reduces glycogen accumulation in skeletal muscle of Japanese quail with acid maltase deficiency. Hum Gene Ther 1998; 9: 1609-1616.
33. Ishii A, Hagiwara Y, Saito Y, et al. Effective adenovirus-mediated gene expression in adult murine skeletal muscle. Muscle Nerve 1999; 22: 592-599.
34. Xu L, Daly T, Gao C, et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther 2001; 12: 563-573.
35. Owen RT, Mandel RJ, Ammini CV, et al. Gene therapy for pyruvate dehydrogenase E1alpha deficiency using recombinant adeno-associated virus 2 (rAAV2) vectors. Mol Ther 2002; 6: 394-399.
36. Tsuji-Yamada J, Nakazawa M, Takahashi K, et al. Effect of IL-12 encoding plasmid administration on tight-skin mouse. Biochem Biophys Res Commun 2001; 280: 707-712.
37. Song S, Embury J, Laipis PJ, Berns KI, Crawford JM, Flotte TR. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther 2001; 8: 1299-1306.
38. Maruyama H, Higuchi N, Nishikawa Y, et al. High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med 2002; 4: 333-341.
39. Schmidt EV, Christoph G, Zeller R, Leder P. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol 1990; 10: 4406-4411.
40. Yoshida Y, Sadata A, Zhang W, Saito K, Shinoura N, Hamada H. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum Gene Ther 1998; 9: 2503-2515.
41. Dehari H, Ito Y, Nakamura T, et al. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer. Cancer Gene Ther 2003; 10: 75-85.
42. Yamauchi A, Ito Y, Morikawa M, et al. Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 2003; in press.
43. Shaper NL, Harduin-Lepers A, Shaper JH. Male germ cell expression of murine beta 4-galactosyltransferase. A 796-base pair genomic region, containing two cAMP-responsive element (CRE)-like elements, mediates male germ cell-specific expression in transgenic mice. J Biol Chem 1994; 269: 25 165-25 171.
44. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989; 244: 1342-1344.
45. Tio RA, Tkebuchava T, Scheuermann TH, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther 1999; 10: 2953-2960.
46. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996; 94: 3281-3290.
47. Thompson JF, Hayes LS, Lloyd DB. Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991; 103: 171-177.
48. Mei Q, Kothary R, Wall L. The tkNeo gene, but not the pgkPuro gene, can influence the ability of the beta-globin LCR to enhance and confer position-independent expression onto the beta-globin gene. Exp Cell Res 2000; 260: 304-312.
49. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A 1992; 89: 10 892-10 895.
50. Nakai H, Herzog RW, Hagstrom JN, et al. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 1998; 91: 4600-4607.
51. Herweijer H, Zhang G, Subbotin VM, Budker V, Williams P, Wolff JA. Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med 2001; 3: 280-291.
52. Wang JM, Zheng H, Sugahara Y, et al. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells. Hum Gene Ther 1996; 7: 1743-1756.
53. Martini F, Lazzarin L, Iaccheri L, et al. Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002; 94: 1037-1048.
54. Malkin D. Simian virus 40 and non-Hodgkin lymphoma. Lancet 2002; 359: 812-813.
55. Carbone M, Rizzo P, Procopio A, et al. SV40-like sequences in human bone tumors. Oncogene 1996; 13: 527-535.
56. Li S, MacLaughlin FC, Fewell JG, et al. Muscle-specific enhancement of gene expression by incorporation of SV40 enhancer in the expression plasmid. Gene Ther 2001; 8: 494-497.